查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2110273

全球周邊神經損傷市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Peripheral Nerve Injuries Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球周邊神經損傷市場預計將從2025年的22億美元成長至2034年的44.9億美元，2026年至2034年的複合年成長率（CAGR）為8.24%。周邊神經損傷市場正經歷顯著成長，這主要歸因於神經損傷及相關疾病發生率的上升。周邊神經損傷由創傷、手術或疾病引起，會導致疼痛、肌肉無力和功能喪失。糖尿病等疾病的日益流行和人口老化推動了對有效治療方法的需求，包括手術干預、神經修復裝置和復健療法。隨著醫療專業人員致力於改善患者預後和恢復功能，周邊神經損傷治療市場預計將進一步擴大。

技術進步在塑造周邊神經損傷市場的未來方面發揮著至關重要的作用。微創手術和神經移植等外科技術的創新正在提高治療效果。此外，先進生物材料和神經導管的研發正在加速受損神經的再生和修復。隨著製造商持續加大研發投入，預計周邊神經損傷市場將在各種醫療機構中得到更廣泛的創新解決方案應用。

此外，以病人為中心的照護和復原理念日益受到重視，這正在影響周邊神經損傷市場的發展軌跡。隨著患者尋求滿足其復健需求的綜合解決方案，將手術介入與復健療法結合的綜合治療方案的需求也日益成長。這一趨勢正推動醫療服務提供者、復健專家和科技公司之間的合作，以開發能夠加速康復並提高生活品質的綜合方法。隨著市場的不斷發展，技術、患者參與以及多學科護理的整合將成為成功的關鍵促進因素。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：我們全面檢驗主要地理區域的市場表現，識別高成長領域和區域趨勢，並深入了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球周邊神經損傷市場：按類型分類

  • 市場分析、洞察與預測
  • 神經功能障礙
  • 斷裂
  • 神經斷裂

第5章 全球周邊神經損傷市場：依治療方法分類

  • 市場分析、洞察與預測
  • 手術治療
  • 非手術治療

第6章 全球周邊神經損傷市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心
  • 專科診所
  • 其他

第7章 全球周邊神經損傷市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Medtronic Plc
    • Stryker Corporation
    • Baxter International Inc
    • Axogen Inc
    • Integra LifeSciences Holdings Corporation
    • Boston Scientific Corporation
    • Abbott Laboratories
    • NeuroPace Inc
    • NeuroMetrix Inc
    • Polyganics BV
    • Toyobo Co. Ltd
    • Synovis Micro Companies Alliance Inc
    • Collagen Matrix Inc
    • Nuvectra Corporation
    • Nevro Corp
簡介目錄
Product Code: VMR11219104

The global peripheral nerve injuries market size is expected to reach USD 4.49 Billion in 2034 from USD 2.20 Billion in 2025, growing at a CAGR of 8.24 during 2026-2034.The Peripheral Nerve Injuries Market is experiencing significant growth as the incidence of nerve injuries and related disorders increases. Peripheral nerve injuries can result from trauma, surgery, or medical conditions, leading to pain, weakness, and loss of function. The rising prevalence of conditions such as diabetes and the growing aging population are driving the demand for effective treatment options, including surgical interventions, nerve repair devices, and rehabilitation therapies. As healthcare providers seek to improve patient outcomes and restore function, the market for peripheral nerve injury treatments is expected to flourish.

Technological advancements are playing a crucial role in shaping the future of the peripheral nerve injuries market. Innovations in surgical techniques, such as minimally invasive procedures and nerve grafting, are enhancing the effectiveness of treatments. Additionally, the development of advanced biomaterials and nerve conduits is improving the regeneration and repair of damaged nerves. As manufacturers continue to invest in research and development, the peripheral nerve injuries market is likely to see increased adoption of innovative solutions across various healthcare settings.

Moreover, the growing emphasis on patient-centered care and rehabilitation is influencing the peripheral nerve injuries market's growth trajectory. As patients seek comprehensive solutions that address their recovery needs, there is a rising demand for integrated treatment plans that combine surgical interventions with rehabilitation therapies. This trend is driving collaboration between healthcare providers, rehabilitation specialists, and technology firms to develop holistic approaches that enhance recovery and improve quality of life. As the market continues to evolve, the integration of technology, patient engagement, and multidisciplinary care will be key drivers of success.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

  • Neuropraxia
  • Axonotmesis
  • Neurotmesis

By Treatment

  • Surgical
  • Non-Surgical

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

COMPANIES PROFILED

  • Medtronic plc, Stryker Corporation, Baxter International Inc., Axogen Inc., Integra LifeSciences Holdings Corporation, Boston Scientific Corporation, Abbott Laboratories, NeuroPace Inc., NeuroMetrix Inc., Polyganics B.V., Toyobo Co. Ltd., Synovis Micro Companies Alliance Inc., Collagen Matrix Inc., Nuvectra Corporation, Nevro Corp.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PERIPHERAL NERVE INJURIES MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Neuropraxia Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Axonotmesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Neurotmesis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PERIPHERAL NERVE INJURIES MARKET: BY TREATMENT 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Treatment
  • 5.2. Surgical Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Non-Surgical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PERIPHERAL NERVE INJURIES MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PERIPHERAL NERVE INJURIES MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Type
    • 7.2.2 By Treatment
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Type
    • 7.3.2 By Treatment
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Type
    • 7.4.2 By Treatment
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Type
    • 7.5.2 By Treatment
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Type
    • 7.6.2 By Treatment
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PERIPHERAL NERVE INJURIES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Medtronic Plc
    • 9.2.2 Stryker Corporation
    • 9.2.3 Baxter International Inc
    • 9.2.4 Axogen Inc
    • 9.2.5 Integra LifeSciences Holdings Corporation
    • 9.2.6 Boston Scientific Corporation
    • 9.2.7 Abbott Laboratories
    • 9.2.8 NeuroPace Inc
    • 9.2.9 NeuroMetrix Inc
    • 9.2.10 Polyganics B.V
    • 9.2.11 Toyobo Co. Ltd
    • 9.2.12 Synovis Micro Companies Alliance Inc
    • 9.2.13 Collagen Matrix Inc
    • 9.2.14 Nuvectra Corporation
    • 9.2.15 Nevro Corp